DL-ADR: a novel deep learning model for classifying genomic variants into adverse drug reactions

Pharmacogenomics in the clinic

(2015) Mary V. Relling et al.   NATURE

Functional influence of human CYP2D6 allelic variations: P34S, E418K, S486T, and R296C

(2013) Joohwan Kim et al.   ARCHIVES OF PHARMACAL RESEARCH

Mining network data for intrusion detection through combining SVMs with ant colony networks

(2013) Wenying Feng et al.   Future Generation Computer Systems-The International Journal of eScience

Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population

(2013) Tian-Bo Jin et al.   GENE

Chapter 11: Genome-Wide Association Studies

(2012) William S. Bush et al.   PLoS Computational Biology

Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations

(2010) Gin Gin Gan et al.   ANNALS OF HEMATOLOGY

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

(2010) J Bray et al.   BRITISH JOURNAL OF CANCER

Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction

(2010) Kristian M. Bailey et al.   Circulation-Cardiovascular Genetics

A map of human genome variation from population-scale sequencing

(2010) Richard M. Durbin et al.   NATURE

Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

(2009) Emma C. Davies et al.   PLoS One